Effectiveness of Vinorelbine/Capecitabine (NX) versus Docetaxel/Doxorubicin/Cyclophosphamide (TAC) in patients non-responding to 2 cycles of neoadjuvant TAC chemotherapy: First Results of the phase III GEPARTRIO-Study by the German Breast Group